Skip to main content
IRTC
NASDAQ Industrial Applications And Services

iRhythm 10-Q: Q3 Revenue $221.6M, $49.8M Litigation Hit, New $300M Revolver

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$110
Mkt Cap
$4.291B
52W Low
$100.7
52W High
$192.47
52W Position info
9.2% above low
Off High info
43% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

IRTC is trading near its 52-week low of $100.7 (9.2% above the low).

Summary

iRhythm's Q3 10-Q confirms $221.6M revenue (up 15%) but shows a $49.8M litigation settlement charge pushing GAAP net loss to $0.90 per share, and discloses a new undrawn $300M revolving credit facility.


Key Events · Earnings and Guidance · IRTC

  • Q3 Revenue Grows 15% to $221.6M

    Revenue rose to $221.6M from $192.9M a year earlier on higher Zio monitor and Zio AT volumes; nine-month revenue was $645.2M, up 20%.

  • $49.8M Litigation Charge Drives GAAP Loss

    Q3 litigation settlement expense of $49.8M (the $50.0M Baxter patent payment) pushed net loss to $29.9M, or $0.90 per share, versus a $5.2M loss a year ago; adjusted EBITDA was still $51.2M.

  • New $300M Undrawn Revolving Credit Facility

    Signed November 3, 2026 with JPMorgan as administrative agent, maturing November 3, 2031 with a springing maturity tied to the 2029 Notes; no amounts borrowed at closing.

  • Liquidity: $394.7M Cash Plus $166.0M Securities

    Cash and equivalents of $394.7M and marketable securities of $166.0M at September 30, 2026; nine-month operating cash flow fell to $29.3M from $54.7M due to the $50.0M Baxter payment.


Analysis · IRTC · Industrial Applications And Services

The 10-Q confirms the Q3 numbers already released the same day but fills in what the 8-K did not. A $49.8M litigation settlement charge in the quarter (the $50.0M Baxter patent payment) dragged GAAP net loss to $29.9M, or $0.90 per share, versus a $5.2M loss a year ago. Underneath that one-time item, gross margin improved to 74% and adjusted EBITDA reached $51.2M. The company also disclosed a new $300M senior secured revolving credit facility signed November 3, 2026, undrawn at closing, which adds liquidity alongside $394.7M of cash and $166.0M of marketable securities. Nine-month operating cash flow fell to $29.3M from $54.7M because of the Baxter payment. The unresolved DOJ matter remains the main overhang, with a November 4, 2026 meeting held to discuss resolution pathways.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, IRTC was trading at $110.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $100.70 to $192.47. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IRTC - Latest Insights

IRTC
Nov 17, 2026, 4:38 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $90.65
Real-time Price: $94.52 info
Change: +$3.87 (+4%) info
Market Cap: $3.145B info
IRTC
Nov 11, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $88.68
Real-time Price: $94.52 info
Change: +$5.84 (+7%) info
Market Cap: $3.145B info
IRTC
Nov 06, 2026, 1:07 PM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $89.20
Real-time Price: $94.52 info
Change: +$5.32 (+6%) info
Market Cap: $3.145B info
IRTC
Nov 05, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $117.50
Real-time Price: $94.52 info
Change: -$22.98 (-20%) info
Market Cap: $3.145B info
IRTC
Nov 05, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $130.19
Real-time Price: $94.52 info
Change: -$35.67 (-27%) info
Market Cap: $3.145B info